Last edition
News about "Acne vulgaris treatment"
Alembic Pharmaceuticals Receives US FDA Approval for Dapsone Gel 5 Percent
Alembic Pharmaceuticals has received US FDA approval for Dapsone Gel 5 percent, a topical treatment for acne vulgaris.
Acne Vulgaris Treatment | 29/06/2026 | By News Bureau
Alembic Pharma Receives US FDA Approval for Generic Tretinoin Cream
Alembic Pharmaceuticals has secured final USFDA approval for its generic Tretinoin Cream USP, 0.05 percent, used in the treatment of acne vulgaris, targeting a US market estimated at USD 76 million.
Acne Vulgaris Treatment | 16/06/2026 | By News Bureau | 135
Alembic Pharmaceuticals Announces US FDA Final Approval for Tretinoin Cream
Alembic Pharmaceuticals has received US Food and Drug Administration (FDA) final approval for Tretinoin Cream USP, 0.05 percent, a generic version of Bausch Health’s Retin-A Cream.
Acne Vulgaris Treatment | 12/06/2026 | By News Bureau | 132
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy